Menu
Your Cart

Septefril-Darnitsa of the tab. of 0.2 mg No. 20

Septefril-Darnitsa of the tab. of 0.2 mg No. 20
Septefril-Darnitsa of the tab. of 0.2 mg No. 20
Septefril-Darnitsa of the tab. of 0.2 mg No. 20
Septefril-Darnitsa of the tab. of 0.2 mg No. 20
Septefril-Darnitsa of the tab. of 0.2 mg No. 20
$17.17
Tax $17.17
  • Stock: In Stock
  • Model: 179457

0% Customers recommend this product

  • 5 Awesome
    0%
  • 4 Great
    0%
  • 3 Average
    0%
  • 2 Bad
    0%
  • 1 Poor
    0%

Reviews Over Septefril-Darnitsa of the tab. of 0.2 mg No. 20

  • (0)

Total Reviews (0)
click here write review to add review for this product.



Description

Pharmacological properties

Dekametoksin ― active pharmaceutical ingredient of medicine ― is quarternary ammonium connection from group of surfactants of cationic type. communication of decamethoxynum with phosphatic groups of lipids of a microbic plasmolemma breaks its permeability and leads to destruction of a bacterial cell.

extensive range of antibacterial activity is characteristic

decamethoxynum. The following microorganisms are sensitive to drug:

  • staphylococcus, including the strains of golden staphylococcus resistant to penicillin;
  • streptococci;
  • a korinebakteriya (including causative agent of diphtheria);
  • Stomatococcus spp.;
  • Enterobacteriaceae;
  • Pseudomonas;
  • spore-forming bacteria;
  • elementary;
  • yeast-like mushrooms (especially Candida albicans);
  • dermatophytes;
  • viruses.

Effects inherent in decamethoxynum:

  • bactericidal;
  • fungicidal;
  • sporotsidny;
  • suppression of activity of Corynebacterium diphtheriae exotoxin;
  • increase in sensitivity of microorganisms to influence of antibiotics.

On specific and nonspecific reactivity of the immune system of an organism decamethoxynum has no impact.

Indication

∎ diseases of an oral cavity, a throat, a throat (for topical administration as a part of complex therapy):

• tonsillitis;

• pharyngitis;

• laryngitis;

• ulitis;

• stomatitis;

• periodontal disease;

• candidosis damages of a mucous membrane of an oral cavity;

• tonsillitis (initial stage).

∎ Carriage of pathogenic Staphylococcus spp., C. diphtheriae, Candida spp. (for the purpose of sanitation of an oral cavity, a throat, a nasopharynx).

∎ After the undergone surgeries in an oral cavity, a drink, a throat (for prevention of infectious complications).

Use

After rinsing of an oral cavity use a bukkalny method of administration of medicine (the tablet has to be in an oral cavity before full resorption). the adult ― on 1 tablet from 4 to 6 times a day after a meal. to avoid meal and drinks during 1 h after use of medicine. treatment duration ― ≤1 week

Contraindication

Hypersensitivity to decamethoxynum or other components of medicine.

Side effects

    Allergic reactions (including skin rash); itch of integuments.
After resorption of a tablet salivation strengthening is possible

.

Special instructions

for the purpose of increase in content of decamethoxynum in saliva needs to swallow as seldom as possible of it in the course of medicine resorption.

to

does not recommend the combined use of medicine with different types of rinsing of a stomatopharynx.

medicine Use more than 1 week can contribute to the development of a microbic imbalance of a throat.

For patients with diabetes needs to take existence in composition of medicine of sugar into account.

Use during pregnancy and feeding by a breast. Clinical trials of safety of use of medicine for pregnant women and during feeding by a breast did not carry out. During pregnancy the intake of decamethoxynum is not recommended. In case of need use of decamethoxynum needs to be interrupted feeding with a breast.

Children. There are no clinical data on use of medicine (efficiency and safety) in the specified age group.

Influence on speed of response at control of vehicles or other mechanisms. No.

Interaction

Antibacterial effect of decamethoxynum amplifies at its combined application with the antibiotics and antimicrobial means having system effect.

Overdose

Data are absent.

Storage conditions

At a temperature of ≤25 °C in original packing.

Specifications

Characteristics
Active ingredients Decamethoxynum
Amount of active ingredient 0.2 mg
Applicant Darnitsa
Code of automatic telephone exchange R02AA20 Various antiseptic agents
Interaction with food Later
Light sensitivity Not sensitive
Market status Traditional
Origin Chemical
Prescription status Without prescription
Primary packing blister
Producer DARNITSA CIAO PHARMACEUTICAL. FIRM
Quantity in packing 20 tablets (2 blisters on 10 pieces)
Release form tablets for internal use
Route of administration For resorption
Sign Domestic
Storage temperature from 15 °C to 25 °C
Trade name Septefril